Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? (Q48872882)

16 February 2018

title

Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? (English)

1 reference

16 February 2018

0 references

1

1 reference

16 February 2018

Barbara Ruozi

3

1 reference

16 February 2018

Anna Ferrari

6

1 reference

16 February 2018

Flavio Forni

8

1 reference

16 February 2018

Maria Angela Vandelli

9

1 reference

16 February 2018

Anna Valeria Vergoni

object named as

Anna Valeria Vergoni

4

0 references

author name string

Luca Badiali

2

1 reference

16 February 2018

Lucia Bondioli

5

1 reference

16 February 2018

Francesco Rivasi

7

1 reference

16 February 2018

publication date

30 September 2011

1 reference

16 February 2018

published in

Nanomedicine

1 reference

16 February 2018

volume

7

1 reference

16 February 2018

issue

3

1 reference

16 February 2018

page(s)

365-382

1 reference

16 February 2018

Polymeric nanoparticles for the drug delivery to the central nervous system

cites work

1 reference

Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats.

21 January 2018

1 reference

Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery

21 January 2018

1 reference

Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.

21 January 2018

1 reference

Brain uptake of thiamine-coated nanoparticles

21 January 2018

1 reference

Brain drug delivery of small molecules using immunoliposomes

21 January 2018

1 reference

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

21 January 2018

1 reference

Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier.

21 January 2018

1 reference

Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.

21 January 2018

1 reference

Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting

21 January 2018

1 reference

Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods

21 January 2018

1 reference

Structure and function of the blood-brain barrier

21 January 2018

1 reference

Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases

21 January 2018

1 reference

A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection.

21 January 2018

1 reference

Regional localization of specific [125I]leptin binding sites in rat forebrain.

21 January 2018

1 reference

Leptin access into the brain: a saturated transport mechanism in obesity.

21 January 2018

1 reference

Ubiquitylation of leptin receptor OB-Ra regulates its clathrin-mediated endocytosis

21 January 2018

1 reference

Convergent trafficking pattern of leptin after endocytosis mediated by ObRa-ObRd

21 January 2018

1 reference

Identification and expression cloning of a leptin receptor, OB-R

21 January 2018

1 reference

Short communication: Tissue distribution of leptin and leptin receptor mRNA in the bovine

21 January 2018

1 reference

Mapping of the interface between leptin and the leptin receptor CRH2 domain.

21 January 2018

1 reference

Development of a pharmacologically improved peptide agonist of the leptin receptor

21 January 2018

1 reference

Epitope mapping of secreted mouse leptin utilizing peripherally administered synthetic peptides

21 January 2018

1 reference

The identification of leptin-derived peptides that are taken up by the brain.

21 January 2018

1 reference

A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery.

21 January 2018

1 reference

Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis.

21 January 2018

1 reference

Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution

21 January 2018

1 reference

Modulation of nucleic acid structure by ligand binding: induction of a DNA.RNA.DNA hybrid triplex by DAPI intercalation.

21 January 2018

1 reference

The use of lead citrate at high pH as an electron-opaque stain in electron microscopy

21 January 2018

1 reference

Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins

21 January 2018

1 reference

Effects of peripheral 5-HT2 and 5-HT3 receptor agonists on food intake in food-deprived and 2-deoxy-D-glucose-treated rats.

21 January 2018

1 reference

Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.

21 January 2018

1 reference

In vivo methods to study uptake of nanoparticles into the brain.

21 January 2018

1 reference

Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects

21 January 2018

1 reference

Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models.

21 January 2018

1 reference

Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier

21 January 2018

1 reference

Near complete rescue of experimental Parkinson's disease with intravenous, non-viral GDNF gene therapy

21 January 2018

1 reference

Lysosomal enzyme replacement of the brain with intravenous non-viral gene transfer.

21 January 2018

1 reference

Global non-viral gene transfer to the primate brain following intravenous administration.

21 January 2018

1 reference

TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs

21 January 2018

1 reference

Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease

21 January 2018

1 reference

Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling.

21 January 2018

1 reference

Neuromedin U partially mediates leptin-induced hypothalamo-pituitary adrenal (HPA) stimulation and has a physiological role in the regulation of the HPA axis in the rat.

21 January 2018

1 reference

Gene expression in arcuate nucleus-median eminence of rats treated with leptin or ciliary neurotrophic factor

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/NNM.11.98

1 reference

16 February 2018

PubMed ID

21957863

1 reference

16 February 2018